Articles related to Pediatrics

“We try to deescalate pharmacotherapy as soon as we can in children. How’s this going to affect puberty? How’s it going to affect growth? We don’t have those long-term data.”

“If acetaminophen is the safest among available options but pregnant women are advised to avoid it because of the risk of ASD and ADHD in exposed offspring, then they are caught between a rock and a hard place.”

A device that restricts blood flow and is worn around the neck, that has not been shown to provide any clinical benefit, is being sold to vulnerable populations—including children as young as 13.

Silent inactivation (where neutralizing antibodies reduce enzymatic activity without clinical symptoms) can go undetected without therapeutic drug monitoring, leading to subtherapeutic asparagine depletion and increased relapse risk.

Austrian medical authorities have emphasized that no non-credentialed individual—let alone a child—may be present or participate in any part of a surgical procedure, regardless of consent or supervision.

Linzess is the first treatment approved for IBS-C in pediatric patients. Patients younger than 2 years can be at risk of serious dehydration and should not take Linzess for any indication.